Skip to main content
NCBI home page
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 1993 Sep;30(9):728–736. doi: 10.1136/jmg.30.9.728

Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 1. Trends across the clinical groups.

L V Nicholson 1, M A Johnson 1, K M Bushby 1, D Gardner-Medwin 1, A Curtis 1, I B Ginjaar 1, J T den Dunnen 1, J L Welch 1, T J Butler 1, E Bakker 1, et al.
PMCID: PMC1016529  PMID: 8411067

Abstract

This multidisciplinary study was undertaken to record the variation in gene and protein expression in a large cohort of patients with well defined clinical phenotypes. The patients, whose ages ranged from 4 years to 66 years, spanned a wide range of disease severity. They represented the first 100 patients who had been examined in Newcastle, had undergone a muscle biopsy, and provided a blood sample for DNA analysis. The study had three aims: to observe any trends in the analyses across the clinical groups, to correlate gene and protein expression in individual patients, and to use the data collected to assess the relative usefulness of different techniques in the diagnosis and prognosis of patients with Duchenne and Becker dystrophy (DMD/BMD). In part 1, we describe the clinical assessment of the patients and the trends that were observed across the cohort. The patients were divided into seven groups. Group 1 had severe DMD (n = 21), group 2 had milder DMD (n = 20), group 3 were intermediate D/BMD patients (n = 9), group 4 had severe BMD (n = 5), and group 5 were more typical BMD patients (n = 31). Some patients were too young to be classified (n = 7) and a group of all the female patients were also classified separately (n = 7). The number of DMD and BMD patients was about equal, in accord with disease prevalence in the north of England, but an unusually high proportion were sporadic cases. Dystrophin labelling (performed with up to three antibodies) on both blots and sections increased gradually across the clinical groups. All histopathological indices, except the proportion of fat in biopsy sections, showed clear trends across the groups.

Full text

PDF
728

Images in this article

732Image
on p.732

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Acsadi G., Dickson G., Love D. R., Jani A., Walsh F. S., Gurusinghe A., Wolff J. A., Davies K. E. Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs. Nature. 1991 Aug 29;352(6338):815–818. doi: 10.1038/352815a0. [DOI] [PubMed] [Google Scholar]
  2. Appleton R. E., Bushby K., Gardner-Medwin D., Welch J., Kelly P. J. Head circumference and intellectual performance of patients with Duchenne muscular dystrophy. Dev Med Child Neurol. 1991 Oct;33(10):884–890. doi: 10.1111/j.1469-8749.1991.tb14797.x. [DOI] [PubMed] [Google Scholar]
  3. Barnea E., Zuk D., Simantov R., Nudel U., Yaffe D. Specificity of expression of the muscle and brain dystrophin gene promoters in muscle and brain cells. Neuron. 1990 Dec;5(6):881–888. doi: 10.1016/0896-6273(90)90348-j. [DOI] [PubMed] [Google Scholar]
  4. Baumbach L. L., Chamberlain J. S., Ward P. A., Farwell N. J., Caskey C. T. Molecular and clinical correlations of deletions leading to Duchenne and Becker muscular dystrophies. Neurology. 1989 Apr;39(4):465–474. doi: 10.1212/wnl.39.4.465. [DOI] [PubMed] [Google Scholar]
  5. Beggs A. H., Hoffman E. P., Kunkel L. M. Additional dystrophin fragment in Becker muscular dystrophy may result from proteolytic cleavage at deletion junctions. Am J Med Genet. 1992 Oct 1;44(3):378–381. doi: 10.1002/ajmg.1320440322. [DOI] [PubMed] [Google Scholar]
  6. Beggs A. H., Hoffman E. P., Snyder J. R., Arahata K., Specht L., Shapiro F., Angelini C., Sugita H., Kunkel L. M. Exploring the molecular basis for variability among patients with Becker muscular dystrophy: dystrophin gene and protein studies. Am J Hum Genet. 1991 Jul;49(1):54–67. [PMC free article] [PubMed] [Google Scholar]
  7. Beggs A. H., Hoffman E. P., Snyder J. R., Arahata K., Specht L., Shapiro F., Angelini C., Sugita H., Kunkel L. M. Exploring the molecular basis for variability among patients with Becker muscular dystrophy: dystrophin gene and protein studies. Am J Hum Genet. 1991 Jul;49(1):54–67. [PMC free article] [PubMed] [Google Scholar]
  8. Bewick G. S., Nicholson L. V., Young C., O'Donnell E., Slater C. R. Different distributions of dystrophin and related proteins at nerve-muscle junctions. Neuroreport. 1992 Oct;3(10):857–860. doi: 10.1097/00001756-199210000-00009. [DOI] [PubMed] [Google Scholar]
  9. Blake D. J., Love D. R., Tinsley J., Morris G. E., Turley H., Gatter K., Dickson G., Edwards Y. H., Davies K. E. Characterization of a 4.8kb transcript from the Duchenne muscular dystrophy locus expressed in Schwannoma cells. Hum Mol Genet. 1992 May;1(2):103–109. doi: 10.1093/hmg/1.2.103. [DOI] [PubMed] [Google Scholar]
  10. Blonden L. A., den Dunnen J. T., van Paassen H. M., Wapenaar M. C., Grootscholten P. M., Ginjaar H. B., Bakker E., Pearson P. L., van Ommen G. J. High resolution deletion breakpoint mapping in the DMD gene by whole cosmid hybridization. Nucleic Acids Res. 1989 Jul 25;17(14):5611–5621. doi: 10.1093/nar/17.14.5611. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Boyce F. M., Beggs A. H., Feener C., Kunkel L. M. Dystrophin is transcribed in brain from a distant upstream promoter. Proc Natl Acad Sci U S A. 1991 Feb 15;88(4):1276–1280. doi: 10.1073/pnas.88.4.1276. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Brooke M. H., Fenichel G. M., Griggs R. C., Mendell J. R., Moxley R., Miller J. P., Province M. A. Clinical investigation in Duchenne dystrophy: 2. Determination of the "power" of therapeutic trials based on the natural history. Muscle Nerve. 1983 Feb;6(2):91–103. doi: 10.1002/mus.880060204. [DOI] [PubMed] [Google Scholar]
  13. Bulman D. E., Murphy E. G., Zubrzycka-Gaarn E. E., Worton R. G., Ray P. N. Differentiation of Duchenne and Becker muscular dystrophy phenotypes with amino- and carboxy-terminal antisera specific for dystrophin. Am J Hum Genet. 1991 Feb;48(2):295–304. [PMC free article] [PubMed] [Google Scholar]
  14. Bulman D. E., Murphy E. G., Zubrzycka-Gaarn E. E., Worton R. G., Ray P. N. Differentiation of Duchenne and Becker muscular dystrophy phenotypes with amino- and carboxy-terminal antisera specific for dystrophin. Am J Hum Genet. 1991 Feb;48(2):295–304. [PMC free article] [PubMed] [Google Scholar]
  15. Burn J., Povey S., Boyd Y., Munro E. A., West L., Harper K., Thomas D. Duchenne muscular dystrophy in one of monozygotic twin girls. J Med Genet. 1986 Dec;23(6):494–500. doi: 10.1136/jmg.23.6.494. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Bushby K. M., Gardner-Medwin D., Nicholson L. V., Johnson M. A., Haggerty I. D., Cleghorn N. J., Harris J. B., Bhattacharya S. S. The clinical, genetic and dystrophin characteristics of Becker muscular dystrophy. II. Correlation of phenotype with genetic and protein abnormalities. J Neurol. 1993 Feb;240(2):105–112. doi: 10.1007/BF00858726. [DOI] [PubMed] [Google Scholar]
  17. Bushby K. M., Gardner-Medwin D., Nicholson L. V., Johnson M. A., Haggerty I. D., Cleghorn N. J., Harris J. B., Bhattacharya S. S. The clinical, genetic and dystrophin characteristics of Becker muscular dystrophy. II. Correlation of phenotype with genetic and protein abnormalities. J Neurol. 1993 Feb;240(2):105–112. doi: 10.1007/BF00858726. [DOI] [PubMed] [Google Scholar]
  18. Bushby K. M., Gardner-Medwin D. The clinical, genetic and dystrophin characteristics of Becker muscular dystrophy. I. Natural history. J Neurol. 1993 Feb;240(2):98–104. doi: 10.1007/BF00858725. [DOI] [PubMed] [Google Scholar]
  19. Bushby K. M., Gardner-Medwin D. The clinical, genetic and dystrophin characteristics of Becker muscular dystrophy. I. Natural history. J Neurol. 1993 Feb;240(2):98–104. doi: 10.1007/BF00858725. [DOI] [PubMed] [Google Scholar]
  20. Bushby K. M., Goodship J. A., Nicholson L. V., Johnson M. A., Haggerty I. D., Gardner-Medwin D. Variability in clinical, genetic and protein abnormalities in manifesting carriers of Duchenne and Becker muscular dystrophy. Neuromuscul Disord. 1993 Jan;3(1):57–64. doi: 10.1016/0960-8966(93)90042-i. [DOI] [PubMed] [Google Scholar]
  21. Bushby K. M., Thambyayah M., Gardner-Medwin D. Prevalence and incidence of Becker muscular dystrophy. Lancet. 1991 Apr 27;337(8748):1022–1024. doi: 10.1016/0140-6736(91)92671-n. [DOI] [PubMed] [Google Scholar]
  22. Chamberlain J. S., Gibbs R. A., Ranier J. E., Nguyen P. N., Caskey C. T. Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification. Nucleic Acids Res. 1988 Dec 9;16(23):11141–11156. doi: 10.1093/nar/16.23.11141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Chelly J., Gilgenkrantz H., Lambert M., Hamard G., Chafey P., Récan D., Katz P., de la Chapelle A., Koenig M., Ginjaar I. B. Effect of dystrophin gene deletions on mRNA levels and processing in Duchenne and Becker muscular dystrophies. Cell. 1990 Dec 21;63(6):1239–1248. doi: 10.1016/0092-8674(90)90419-f. [DOI] [PubMed] [Google Scholar]
  24. Chelly J., Hamard G., Koulakoff A., Kaplan J. C., Kahn A., Berwald-Netter Y. Dystrophin gene transcribed from different promoters in neuronal and glial cells. Nature. 1990 Mar 1;344(6261):64–65. doi: 10.1038/344064a0. [DOI] [PubMed] [Google Scholar]
  25. Cooke A., Lanyon W. G., Wilcox D. E., Dornan E. S., Kataki A., Gillard E. F., McWhinnie A. J., Morris A., Ferguson-Smith M. A., Connor J. M. Analysis of Scottish Duchenne and Becker muscular dystrophy families with dystrophin cDNA probes. J Med Genet. 1990 May;27(5):292–297. doi: 10.1136/jmg.27.5.292. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Cornelio F., Dworzak F., Morandi L., Fedrizzi E., Balestrini M. R., Gondoni L. Functional evaluation of Duchenne muscular dystrophy: proposal for a protocol. Ital J Neurol Sci. 1982 Dec;3(4):323–330. doi: 10.1007/BF02043581. [DOI] [PubMed] [Google Scholar]
  27. Darras B. T., Koenig M., Kunkel L. M., Francke U. Direct method for prenatal diagnosis and carrier detection in Duchenne/Becker muscular dystrophy using the entire dystrophin cDNA. Am J Med Genet. 1988 Mar;29(3):713–726. doi: 10.1002/ajmg.1320290341. [DOI] [PubMed] [Google Scholar]
  28. Den Dunnen J. T., Grootscholten P. M., Bakker E., Blonden L. A., Ginjaar H. B., Wapenaar M. C., van Paassen H. M., van Broeckhoven C., Pearson P. L., van Ommen G. J. Topography of the Duchenne muscular dystrophy (DMD) gene: FIGE and cDNA analysis of 194 cases reveals 115 deletions and 13 duplications. Am J Hum Genet. 1989 Dec;45(6):835–847. [PMC free article] [PubMed] [Google Scholar]
  29. Den Dunnen J. T., Grootscholten P. M., Bakker E., Blonden L. A., Ginjaar H. B., Wapenaar M. C., van Paassen H. M., van Broeckhoven C., Pearson P. L., van Ommen G. J. Topography of the Duchenne muscular dystrophy (DMD) gene: FIGE and cDNA analysis of 194 cases reveals 115 deletions and 13 duplications. Am J Hum Genet. 1989 Dec;45(6):835–847. [PMC free article] [PubMed] [Google Scholar]
  30. Dickson G., Love D. R., Davies K. E., Wells K. E., Piper T. A., Walsh F. S. Human dystrophin gene transfer: production and expression of a functional recombinant DNA-based gene. Hum Genet. 1991 Nov;88(1):53–58. doi: 10.1007/BF00204929. [DOI] [PubMed] [Google Scholar]
  31. Dunckley M. G., Love D. R., Davies K. E., Walsh F. S., Morris G. E., Dickson G. Retroviral-mediated transfer of a dystrophin minigene into mdx mouse myoblasts in vitro. FEBS Lett. 1992 Jan 20;296(2):128–134. doi: 10.1016/0014-5793(92)80363-l. [DOI] [PubMed] [Google Scholar]
  32. England S. B., Nicholson L. V., Johnson M. A., Forrest S. M., Love D. R., Zubrzycka-Gaarn E. E., Bulman D. E., Harris J. B., Davies K. E. Very mild muscular dystrophy associated with the deletion of 46% of dystrophin. Nature. 1990 Jan 11;343(6254):180–182. doi: 10.1038/343180a0. [DOI] [PubMed] [Google Scholar]
  33. Feener C. A., Koenig M., Kunkel L. M. Alternative splicing of human dystrophin mRNA generates isoforms at the carboxy terminus. Nature. 1989 Apr 6;338(6215):509–511. doi: 10.1038/338509a0. [DOI] [PubMed] [Google Scholar]
  34. Francke U., Darras B. T., Hersh J. H., Berg B. O., Miller R. G. Brother/sister pairs affected with early-onset, progressive muscular dystrophy: molecular studies reveal etiologic heterogeneity. Am J Hum Genet. 1989 Jul;45(1):63–72. [PMC free article] [PubMed] [Google Scholar]
  35. Gangopadhyay S. B., Sherratt T. G., Heckmatt J. Z., Dubowitz V., Miller G., Shokeir M., Ray P. N., Strong P. N., Worton R. G. Dystrophin in frameshift deletion patients with Becker muscular dystrophy. Am J Hum Genet. 1992 Sep;51(3):562–570. [PMC free article] [PubMed] [Google Scholar]
  36. Gillard E. F., Chamberlain J. S., Murphy E. G., Duff C. L., Smith B., Burghes A. H., Thompson M. W., Sutherland J., Oss I., Bodrug S. E. Molecular and phenotypic analysis of patients with deletions within the deletion-rich region of the Duchenne muscular dystrophy (DMD) gene. Am J Hum Genet. 1989 Oct;45(4):507–520. [PMC free article] [PubMed] [Google Scholar]
  37. Hodgson S. V., Abbs S., Clark S., Manzur A., Heckmatt J. Z., Dubowitz V., Bobrow M. Correlation of clinical and deletion data in Duchenne and Becker muscular dystrophy, with special reference to mental ability. Neuromuscul Disord. 1992;2(4):269–276. doi: 10.1016/0960-8966(92)90059-f. [DOI] [PubMed] [Google Scholar]
  38. Hodgson S., Hart K., Abbs S., Heckmatt J., Rodillo E., Bobrow M., Dubowitz V. Correlation of clinical and deletion data in Duchenne and Becker muscular dystrophy. J Med Genet. 1989 Nov;26(11):682–693. doi: 10.1136/jmg.26.11.682. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Hoffman E. P., Brown R. H., Jr, Kunkel L. M. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell. 1987 Dec 24;51(6):919–928. doi: 10.1016/0092-8674(87)90579-4. [DOI] [PubMed] [Google Scholar]
  40. Hoffman E. P., Brown R. H., Jr, Kunkel L. M. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell. 1987 Dec 24;51(6):919–928. doi: 10.1016/0092-8674(87)90579-4. [DOI] [PubMed] [Google Scholar]
  41. Hoffman E. P., Fischbeck K. H., Brown R. H., Johnson M., Medori R., Loike J. D., Harris J. B., Waterston R., Brooke M., Specht L. Characterization of dystrophin in muscle-biopsy specimens from patients with Duchenne's or Becker's muscular dystrophy. N Engl J Med. 1988 May 26;318(21):1363–1368. doi: 10.1056/NEJM198805263182104. [DOI] [PubMed] [Google Scholar]
  42. Hoffman E. P., Fischbeck K. H., Brown R. H., Johnson M., Medori R., Loike J. D., Harris J. B., Waterston R., Brooke M., Specht L. Characterization of dystrophin in muscle-biopsy specimens from patients with Duchenne's or Becker's muscular dystrophy. N Engl J Med. 1988 May 26;318(21):1363–1368. doi: 10.1056/NEJM198805263182104. [DOI] [PubMed] [Google Scholar]
  43. Hoffman E. P., Kunkel L. M., Angelini C., Clarke A., Johnson M., Harris J. B. Improved diagnosis of Becker muscular dystrophy by dystrophin testing. Neurology. 1989 Aug;39(8):1011–1017. doi: 10.1212/wnl.39.8.1011. [DOI] [PubMed] [Google Scholar]
  44. Hoffman E. P., Kunkel L. M., Angelini C., Clarke A., Johnson M., Harris J. B. Improved diagnosis of Becker muscular dystrophy by dystrophin testing. Neurology. 1989 Aug;39(8):1011–1017. doi: 10.1212/wnl.39.8.1011. [DOI] [PubMed] [Google Scholar]
  45. Hoffman E. P., Kunkel L. M. Dystrophin abnormalities in Duchenne/Becker muscular dystrophy. Neuron. 1989 Jan;2(1):1019–1029. doi: 10.1016/0896-6273(89)90226-2. [DOI] [PubMed] [Google Scholar]
  46. Hoffman E. P., Morgan J. E., Watkins S. C., Partridge T. A. Somatic reversion/suppression of the mouse mdx phenotype in vivo. J Neurol Sci. 1990 Oct;99(1):9–25. doi: 10.1016/0022-510x(90)90195-s. [DOI] [PubMed] [Google Scholar]
  47. Kaplan L. C., Osborne P., Elias E. The diagnosis of muscular dystrophy in patients referred for language delay. J Child Psychol Psychiatry. 1986 Jul;27(4):545–549. doi: 10.1111/j.1469-7610.1986.tb00641.x. [DOI] [PubMed] [Google Scholar]
  48. Karagan N. J., Richman L. C., Sorensen J. P. Analysis of verbal disability in Duchenne muscular dystrophy. J Nerv Ment Dis. 1980 Jul;168(7):419–423. doi: 10.1097/00005053-198007000-00005. [DOI] [PubMed] [Google Scholar]
  49. Khurana T. S., Hoffman E. P., Kunkel L. M. Identification of a chromosome 6-encoded dystrophin-related protein. J Biol Chem. 1990 Oct 5;265(28):16717–16720. [PubMed] [Google Scholar]
  50. Koenig M., Beggs A. H., Moyer M., Scherpf S., Heindrich K., Bettecken T., Meng G., Müller C. R., Lindlöf M., Kaariainen H. The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion. Am J Hum Genet. 1989 Oct;45(4):498–506. [PMC free article] [PubMed] [Google Scholar]
  51. Koenig M., Beggs A. H., Moyer M., Scherpf S., Heindrich K., Bettecken T., Meng G., Müller C. R., Lindlöf M., Kaariainen H. The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion. Am J Hum Genet. 1989 Oct;45(4):498–506. [PMC free article] [PubMed] [Google Scholar]
  52. Koenig M., Hoffman E. P., Bertelson C. J., Monaco A. P., Feener C., Kunkel L. M. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell. 1987 Jul 31;50(3):509–517. doi: 10.1016/0092-8674(87)90504-6. [DOI] [PubMed] [Google Scholar]
  53. Koenig M., Kunkel L. M. Detailed analysis of the repeat domain of dystrophin reveals four potential hinge segments that may confer flexibility. J Biol Chem. 1990 Mar 15;265(8):4560–4566. [PubMed] [Google Scholar]
  54. Koenig M., Monaco A. P., Kunkel L. M. The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein. Cell. 1988 Apr 22;53(2):219–228. doi: 10.1016/0092-8674(88)90383-2. [DOI] [PubMed] [Google Scholar]
  55. Koenig M., Monaco A. P., Kunkel L. M. The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein. Cell. 1988 Apr 22;53(2):219–228. doi: 10.1016/0092-8674(88)90383-2. [DOI] [PubMed] [Google Scholar]
  56. Lederfein D., Levy Z., Augier N., Mornet D., Morris G., Fuchs O., Yaffe D., Nudel U. A 71-kilodalton protein is a major product of the Duchenne muscular dystrophy gene in brain and other nonmuscle tissues. Proc Natl Acad Sci U S A. 1992 Jun 15;89(12):5346–5350. doi: 10.1073/pnas.89.12.5346. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Leibowitz D., Dubowitz V. Intellect and behaviour in Duchenne muscular dystrophy. Dev Med Child Neurol. 1981 Oct;23(5):577–590. doi: 10.1111/j.1469-8749.1981.tb02039.x. [DOI] [PubMed] [Google Scholar]
  58. Love D. R., England S. B., Speer A., Marsden R. F., Bloomfield J. F., Roche A. L., Cross G. S., Mountford R. C., Smith T. J., Davies K. E. Sequences of junction fragments in the deletion-prone region of the dystrophin gene. Genomics. 1991 May;10(1):57–67. doi: 10.1016/0888-7543(91)90484-v. [DOI] [PubMed] [Google Scholar]
  59. Love D. R., Flint T. J., Genet S. A., Middleton-Price H. R., Davies K. E. Becker muscular dystrophy patient with a large intragenic dystrophin deletion: implications for functional minigenes and gene therapy. J Med Genet. 1991 Dec;28(12):860–864. doi: 10.1136/jmg.28.12.860. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Love D. R., Hill D. F., Dickson G., Spurr N. K., Byth B. C., Marsden R. F., Walsh F. S., Edwards Y. H., Davies K. E. An autosomal transcript in skeletal muscle with homology to dystrophin. Nature. 1989 May 4;339(6219):55–58. doi: 10.1038/339055a0. [DOI] [PubMed] [Google Scholar]
  61. Malhotra S. B., Hart K. A., Klamut H. J., Thomas N. S., Bodrug S. E., Burghes A. H., Bobrow M., Harper P. S., Thompson M. W., Ray P. N. Frame-shift deletions in patients with Duchenne and Becker muscular dystrophy. Science. 1988 Nov 4;242(4879):755–759. doi: 10.1126/science.3055295. [DOI] [PubMed] [Google Scholar]
  62. McGuire S. A., Fischbeck K. H. Autosomal recessive Duchenne-like muscular dystrophy: molecular and histochemical results. Muscle Nerve. 1991 Dec;14(12):1209–1212. doi: 10.1002/mus.880141212. [DOI] [PubMed] [Google Scholar]
  63. Medori R., Brooke M. H., Waterston R. H. Genetic abnormalities in Duchenne and Becker dystrophies: clinical correlations. Neurology. 1989 Apr;39(4):461–465. doi: 10.1212/wnl.39.4.461. [DOI] [PubMed] [Google Scholar]
  64. Monaco A. P., Bertelson C. J., Liechti-Gallati S., Moser H., Kunkel L. M. An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. Genomics. 1988 Jan;2(1):90–95. doi: 10.1016/0888-7543(88)90113-9. [DOI] [PubMed] [Google Scholar]
  65. Nicholson L. V., Bushby K. M., Johnson M. A., Gardner-Medwin D., Ginjaar I. B. Dystrophin expression in Duchenne patients with "in-frame" gene deletions. Neuropediatrics. 1993 Apr;24(2):93–97. doi: 10.1055/s-2008-1071521. [DOI] [PubMed] [Google Scholar]
  66. Nicholson L. V., Bushby K. M., Johnson M. A., den Dunnen J. T., Ginjaar I. B., van Ommen G. J. Predicted and observed sizes of dystrophin in some patients with gene deletions that disrupt the open reading frame. J Med Genet. 1992 Dec;29(12):892–896. doi: 10.1136/jmg.29.12.892. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Nicholson L. V., Bushby K. M., Johnson M. A., den Dunnen J. T., Ginjaar I. B., van Ommen G. J. Predicted and observed sizes of dystrophin in some patients with gene deletions that disrupt the open reading frame. J Med Genet. 1992 Dec;29(12):892–896. doi: 10.1136/jmg.29.12.892. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Nicholson L. V., Davison K., Falkous G., Harwood C., O'Donnell E., Slater C. R., Harris J. B. Dystrophin in skeletal muscle. I. Western blot analysis using a monoclonal antibody. J Neurol Sci. 1989 Dec;94(1-3):125–136. doi: 10.1016/0022-510x(89)90223-2. [DOI] [PubMed] [Google Scholar]
  69. Nicholson L. V., Johnson M. A., Bushby K. M., Gardner-Medwin D. Functional significance of dystrophin positive fibres in Duchenne muscular dystrophy. Arch Dis Child. 1993 May;68(5):632–636. doi: 10.1136/adc.68.5.632. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Nicholson L. V., Johnson M. A., Davison K., O'Donnell E., Falkous G., Barron M., Harris J. B. Dystrophin or a "related protein" in Duchenne muscular dystrophy? Acta Neurol Scand. 1992 Jul;86(1):8–14. doi: 10.1111/j.1600-0404.1992.tb08046.x. [DOI] [PubMed] [Google Scholar]
  71. Nicholson L. V., Johnson M. A., Gardner-Medwin D., Bhattacharya S., Harris J. B. Heterogeneity of dystrophin expression in patients with Duchenne and Becker muscular dystrophy. Acta Neuropathol. 1990;80(3):239–250. doi: 10.1007/BF00294640. [DOI] [PubMed] [Google Scholar]
  72. Nicholson L. V., Johnson M. A., Gardner-Medwin D., Bhattacharya S., Harris J. B. Heterogeneity of dystrophin expression in patients with Duchenne and Becker muscular dystrophy. Acta Neuropathol. 1990;80(3):239–250. doi: 10.1007/BF00294640. [DOI] [PubMed] [Google Scholar]
  73. Norman A. M., Hughes H. E., Gardner-Medwin D., Nicholson L. V. Dystrophin analysis in the diagnosis of muscular dystrophy. Arch Dis Child. 1989 Oct;64(10):1501–1503. doi: 10.1136/adc.64.10.1501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Norman A. M., Thomas N. S., Kingston H. M., Harper P. S. Becker muscular dystrophy: correlation of deletion type with clinical severity. J Med Genet. 1990 Apr;27(4):236–239. doi: 10.1136/jmg.27.4.236. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Nudel U., Zuk D., Einat P., Zeelon E., Levy Z., Neuman S., Yaffe D. Duchenne muscular dystrophy gene product is not identical in muscle and brain. Nature. 1989 Jan 5;337(6202):76–78. doi: 10.1038/337076a0. [DOI] [PubMed] [Google Scholar]
  76. Passos-Bueno M. R., Bakker E., Kneppers A. L., Takata R. I., Rapaport D., den Dunnen J. T., Zatz M., van Ommen G. J. Different mosaicism frequencies for proximal and distal Duchenne muscular dystrophy (DMD) mutations indicate difference in etiology and recurrence risk. Am J Hum Genet. 1992 Nov;51(5):1150–1155. [PMC free article] [PubMed] [Google Scholar]
  77. Passos-Bueno M. R., Rapaport D., Love D., Flint T., Bortolini E. R., Zatz M., Davies K. E. Screening of deletions in the dystrophin gene with the cDNA probes Cf23a, Cf56a, and Cf115. J Med Genet. 1990 Mar;27(3):145–150. doi: 10.1136/jmg.27.3.145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Pizzuti A., Pieretti M., Fenwick R. G., Gibbs R. A., Caskey C. T. A transposon-like element in the deletion-prone region of the dystrophin gene. Genomics. 1992 Jul;13(3):594–600. doi: 10.1016/0888-7543(92)90129-g. [DOI] [PubMed] [Google Scholar]
  79. Rapaport D., Passos-Bueno M. R., Brandão L., Love D., Vainzof M., Zatz M. Apparent association of mental retardation and specific patterns of deletions screened with probes cf56a and cf23a in Duchenne muscular dystrophy. Am J Med Genet. 1991 Jun 15;39(4):437–441. doi: 10.1002/ajmg.1320390414. [DOI] [PubMed] [Google Scholar]
  80. Rapaport D., Passos-Bueno M. R., Takata R. I., Campiotto S., Eggers S., Vainzof M., Makover A., Nudel U., Yaffe D., Zatz M. A deletion including the brain promoter of the Duchenne muscular dystrophy gene is not associated with mental retardation. Neuromuscul Disord. 1992;2(2):117–120. doi: 10.1016/0960-8966(92)90043-6. [DOI] [PubMed] [Google Scholar]
  81. Roberts R. G., Barby T. F., Manners E., Bobrow M., Bentley D. R. Direct detection of dystrophin gene rearrangements by analysis of dystrophin mRNA in peripheral blood lymphocytes. Am J Hum Genet. 1991 Aug;49(2):298–310. [PMC free article] [PubMed] [Google Scholar]
  82. Roberts R. G., Bobrow M., Bentley D. R. Point mutations in the dystrophin gene. Proc Natl Acad Sci U S A. 1992 Mar 15;89(6):2331–2335. doi: 10.1073/pnas.89.6.2331. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. SEASHORE H. G. Differences between verbal and performance IQs on the Wechsler Intelligence Scale for Children. J Consult Psychol. 1951 Feb;15(1):62–67. doi: 10.1037/h0060790. [DOI] [PubMed] [Google Scholar]
  84. SEASHORE H., WESMAN A., DOPPELT J. The standardization of the Wechsler intelligence scale for children. J Consult Psychol. 1950 Apr;14(2):99–110. doi: 10.1037/h0056307. [DOI] [PubMed] [Google Scholar]
  85. Slater C. R., Nicholson L. V. Is dystrophin labelling always discontinuous in Becker muscular dystrophy? J Neurol Sci. 1991 Feb;101(2):187–192. doi: 10.1016/0022-510x(91)90044-8. [DOI] [PubMed] [Google Scholar]
  86. Smith T. J., Forrest S. M., Cross G. S., Davies K. E. Duchenne and Becker muscular dystrophy mutations: analysis using 2.6 kb of muscle cDNA from the 5' end of the gene. Nucleic Acids Res. 1987 Dec 10;15(23):9761–9769. doi: 10.1093/nar/15.23.9761. [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. Specht L. A., Beggs A. H., Korf B., Kunkel L. M., Shapiro F. Prediction of dystrophin phenotype by DNA analysis in Duchenne/Becker muscular dystrophy. Pediatr Neurol. 1992 Nov-Dec;8(6):432–436. doi: 10.1016/0887-8994(92)90004-i. [DOI] [PubMed] [Google Scholar]
  88. Tachi N., Tachi M., Sasaki K., Nagata N., Chiba S. Dystrophin analysis in the differential diagnosis of autosomal recessive muscular dystrophy of childhood and Duchenne muscular dystrophy. Pediatr Neurol. 1990 Jul-Aug;6(4):265–268. doi: 10.1016/0887-8994(90)90119-l. [DOI] [PubMed] [Google Scholar]
  89. Vainzof M., Passos-Bueno M. R., Rapaport D., Pavanello R. C., Zatz M., Bulman D. E. Additional dystrophin fragment in Becker muscular dystrophy patients: correlation with the pattern of DNA deletion. Am J Med Genet. 1992 Oct 1;44(3):382–384. doi: 10.1002/ajmg.1320440323. [DOI] [PubMed] [Google Scholar]
  90. Vainzof M., Pavanello R. C., Pavanello-Filho I., Rapaport D., Passos-Bueno M. R., Zubrzycka-Gaarn E. E., Bulman D. E., Zatz M. Screening of male patients with autosomal recessive Duchenne dystrophy through dystrophin and DNA studies. Am J Med Genet. 1991 Apr 1;39(1):38–41. doi: 10.1002/ajmg.1320390110. [DOI] [PubMed] [Google Scholar]
  91. Voit T., Stuettgen P., Cremer M., Goebel H. H. Dystrophin as a diagnostic marker in Duchenne and Becker muscular dystrophy. Correlation of immunofluorescence and western blot. Neuropediatrics. 1991 Aug;22(3):152–162. doi: 10.1055/s-2008-1071434. [DOI] [PubMed] [Google Scholar]
  92. Voit T., Stuettgen P., Cremer M., Goebel H. H. Dystrophin as a diagnostic marker in Duchenne and Becker muscular dystrophy. Correlation of immunofluorescence and western blot. Neuropediatrics. 1991 Aug;22(3):152–162. doi: 10.1055/s-2008-1071434. [DOI] [PubMed] [Google Scholar]
  93. Weibel E. R., Kistler G. S., Scherle W. F. Practical stereological methods for morphometric cytology. J Cell Biol. 1966 Jul;30(1):23–38. doi: 10.1083/jcb.30.1.23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  94. Wells D. J., Wells K. E., Walsh F. S., Davies K. E., Goldspink G., Love D. R., Chan-Thomas P., Dunckley M. G., Piper T., Dickson G. Human dystrophin expression corrects the myopathic phenotype in transgenic mdx mice. Hum Mol Genet. 1992 Apr;1(1):35–40. doi: 10.1093/hmg/1.1.35. [DOI] [PubMed] [Google Scholar]
  95. den Dunnen J. T., Casula L., Makover A., Bakker B., Yaffe D., Nudel U., van Ommen G. J. Mapping of dystrophin brain promoter: a deletion of this region is compatible with normal intellect. Neuromuscul Disord. 1991;1(5):327–331. doi: 10.1016/0960-8966(91)90118-c. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES